Motor neuron diseases (MNDs) are a large class of neurodegenerative diseases in which upper cortical and lower spinal cord motorneuron are affected. Several MNDs, like spinal and bulbar muscular atrophy (SBMA) or amyotrophic lateral sclerosis (ALS) have been linked to specific gene mutation which results in the production of aberrant proteins prone to misfold and to aggregate. To counteract the accumulation of these misfolded proteins cells, including neurons have developed a finely tuned protein quality control (PQC). The degradative systems are major components of the PQC system and comprise the ubiquitin-proteasome pathway and the autophagic pathways, specifically involved in the maintenance of a normal cell proteostasts. By working in association to salacted molecular chaperones, the degradative systems are essential components of the intracellular protein quality control (PQC) system. Misfolded proteins are neurotoxic and are recognized by chaperones and deleivered to degradative systems for their clearance. A tightly molecularly regulated equilibrium oversees the final fate of aberrant proteins. This equilibrium is crucial to mantain proteostasis in neurons and may chance under various stimuli, and its alteration give rise to a vicious cycle of protein accumulation and to the PQC system damage that might lead to cell death. Among chaperones, the small heat shock protein (HSP) B8, is able to facilitate autophagy and assist the removal of misfolded proteins prone to aggregate in MNDs. HSPB8 associates to BAG3, HSP70 and CHIP (an ubiquitinating enzyme) to deliver misfolded protein to autophagosome and this form of autophagy is called Chaperone-assisted selective autophagy (CASA) and the complex based on HSPB8/BAG3 s named CASA complex. HSPB8 is induced in response to se several neuronal stresses such has proteotoxic and oxidative stresses. We found that HSPB8 is highly induced in two main targets of misfolded protein toxicity in tg mice models of SBMA and ALS, the motorneurons and the muscle. The pharmacological or genetic induction of HSPB8 expression is protective in MNDs, while its siliencing has opposite effects. We also showed that HSPB8 protects from a misfolded protein induced abberant phenotype in fly models of ALS. By increasing HSPB8-mediated selective targeting of misfolded protein to autophagy neurons and muscle reduce their proteasome-mediated clearance limiting its possible overwhelming. Therefore, pharmacological approached which potentiate the HSPB8-BAG3 autophagic pathway could contribute to maintain a correct proteinostasis in motorneuron and muscle cells and might have therapeutic implication in MNDs.
The small heat shock protein B8 at the interplay between the intracellular degradative pathways in motoneuron disease / A. Poletti, R. Cristofani, V. Crippa, P. Rusmini, M.E. Cicardi, V. Ferrari, B. Tedesco, M. Meroni, M. Galbiati, S. Cerra. ((Intervento presentato al 3. convegno CSSI workshop on small heat shock proteins tenutosi a Quebec city nel 2018.
|Titolo:||The small heat shock protein B8 at the interplay between the intracellular degradative pathways in motoneuron disease|
|Data di pubblicazione:||ago-2018|
|Settore Scientifico Disciplinare:||Settore BIO/13 - Biologia Applicata|
Settore BIO/09 - Fisiologia
|Citazione:||The small heat shock protein B8 at the interplay between the intracellular degradative pathways in motoneuron disease / A. Poletti, R. Cristofani, V. Crippa, P. Rusmini, M.E. Cicardi, V. Ferrari, B. Tedesco, M. Meroni, M. Galbiati, S. Cerra. ((Intervento presentato al 3. convegno CSSI workshop on small heat shock proteins tenutosi a Quebec city nel 2018.|
|Appare nelle tipologie:||14 - Intervento a convegno non pubblicato|